5121612025-01-012025-03-315121612025-03-315121612024-03-315121612024-04-012025-03-315121612025-01-012025-03-31in-capmkt:OtherExpenses1Member5121612025-01-012025-03-31in-capmkt:OtherExpenses2Member5121612025-01-012025-03-31in-capmkt:OtherExpenses3Member5121612025-01-012025-03-31in-capmkt:OtherExpenses4Member5121612025-01-012025-03-31in-capmkt:OtherExpenses5Member5121612025-01-012025-03-31in-capmkt:OtherExpenses6Member5121612025-01-012025-03-31in-capmkt:OtherExpenses7Member5121612025-01-012025-03-31in-capmkt:OtherExpenses8Member5121612025-01-012025-03-31in-capmkt:OtherExpenses9Member5121612025-01-012025-03-31in-capmkt:OtherExpenses10Member5121612024-04-012025-03-31in-capmkt:OtherExpenses1Member5121612024-04-012025-03-31in-capmkt:OtherExpenses2Member5121612024-04-012025-03-31in-capmkt:OtherExpenses3Member5121612024-04-012025-03-31in-capmkt:OtherExpenses4Member5121612024-04-012025-03-31in-capmkt:OtherExpenses5Member5121612024-04-012025-03-31in-capmkt:OtherExpenses6Member5121612024-04-012025-03-31in-capmkt:OtherExpenses7Member5121612024-04-012025-03-31in-capmkt:OtherExpenses8Member5121612024-04-012025-03-31in-capmkt:OtherExpenses9Member5121612024-04-012025-03-31in-capmkt:OtherExpenses10Member5121612025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares512161SECURKLOUDNOTLISTEDINE650K01021SECUREKLOUD TECHNOLOGIES LIMITEDMain BoardEquity2024-04-012025-03-312025-05-302025-05-23INRLakhsQuarterlyFourth quarterSingle segmentInformation Technology Services2025-05-3013:30:002025-05-3015:30:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated35958500013154000372739000000321132000592520001528800098318000493990000-1212510000-121251000-22310001996000-2350000-1210160000000-1210160002243000-11877300024660000-14567600026903000-14567600016705300050.810.81000.810.81Notes <BR> <BR> 1. The above consolidated financial results for the quarter and twelve months ended March 31 2025 were reviewed by the audit committee and approved by the Board of Directors in its meeting held on May 30 2025 in line with Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015 The Statutory auditors of the Company have carried out an audit of the consolidated financial results and have issued an unmodified review opinion on the same in accordance with SEBI Circular No CIR CFD CMD1 44 2019 dated March 29 2019 The review report of the statutory auditors is being filed with the National Stock Exchange of India Limited NSE and BSE Ltd BSE and is also available on the Companys website The Consolidated financial results have been prepared in accordance with applicable Indian Accounting Standards as prescribed under Section 133 of the Companies Act 2013 read with Rule 3 of the Companies Indian Accounting Standards Rules 2015 as amended from time to time <BR> <BR> 2. The Company operates in a single segment ie Information and Technology Services and hence does not have any additional disclosures to be made under Ind AS 108 Operating Segments <BR> <BR> <BR> 3. On October 21 2024 Healthcare Triangle Inc Company acquired all of the business assets and operations relating to cloud and technology domain of SecureKloud Technologies Inc Target a Nevada corporation. This a common control transaction and the consideration for the Acquired Assets consisted of the issuance of 1600000 shares Series B Convertible Preferred Stock in the Company which may be convertible each into 10 common shares at the holders option subject to shareholders approval for a total consideration of USD 7 point 44 million <BR> <BR> 4. On February 27 2025 Healthcare Triangle Inc the Company entered into Securities Purchase Agreements dated February 27 2025 the Purchase Agreement with institutional investors the Investors for the private placement of 36 190 485 units each a Unit each Unit consisting of one share of the Companys common stock Common Stock or one pre funded warrant a Pre Funded Warrant to purchase one share of common stock one Series A Warrant a Series A Warrant to purchase one share of common stock and one Series B Warrant a Series B Warrant and together with the Series A Warrant the Purchase Warrants to purchase one share of common stock at an offering price of dollar 0 point 42 per Unit or 0 point 41999 per Unit in the case of Units that include pre-funded warrants The entire transaction has been priced at the market under Nasdaq rules and closed on February 28 2025 <BR> <BR> 5. SecureKloud Technologies Limited the Company consolidates the financial statements of its overseas subsidiary in accordance with Indian Accounting Standard Ind AS 110 Consolidated Financial Statements Mr Suresh Venkatachari Chairman of the Company holds 20000 Series A Preferred Stocks 1000 votes per Series A preferred stock in Healthcare Triangle Inc which gives the Company 55 percent of the voting rights The Board has evaluated the governance structure and voting rights in Healthcare Triangle Inc its overseas subsidiary and concluded that it exercises control as defined under Ind AS 110 Accordingly the financial statements of the overseas subsidiary have been consolidated line by line on a uniform accounting basis after eliminating all intra group balances transactions unrealized gains and losses <BR> <BR> 6. On May 27 2025 QuantumNexis Inc a 100 percent subsidiary of Healthcare Triangle Inc announced the acquisitions of Niyama Healthcare Inc and Ezovion Solutions for an aggregate consideration up to Five Million Seven Hundred Thousand Dollars 5700000 payable 1500000 as upfront cash 3000000 in common stocks and an earn out of up to 1200000 payable in cash based on the achievement of certain agreedupon financial targets during the first 12 months following the closing date <BR> <BR> 7. The financial statements do not include any adjustments that might result from the outcome of this uncertainty Our opinion is not modified in respect of the above matter <BR> <BR> 8. The figures for the quarters ended March 31 2025 and March 31 2024 are the balancing figures between the audited figures for the year ended March 31 2025 and March 31 2024 and unaudited year to date figures for the nine months ended December 31 2024 and December 31 2023 respectively which were subject to limited review by the Statutory Auditors <BR> <BR> 9.The figures in the previous period financial results have been reclassified to confirm to the presentation of the current quarter financial results These reclassifications have no effect on the previously reported net loss profit2024-04-012025-03-31AuditedConsolidated16766680002945800017061260000001557992000161456000790330003620720002160553000-4544270000-454427000304400084700038910000-4583180000000-4583180002426000-455892000-139310000-319008000-136884000-3190080001670530005592357000-4.1-4.100-4.1-4.1Professional and Consultancy Charges27177000Rent5375000Repairs and maintenance2990000Insurance expenses7277000Fees, Rates and taxes4187000Sales and Marketing Expenses7228000Cloud Hosting and Communication Charges18593000Payments to auditors1216000Bank Charges2243000Miscellaneous expenses22032000Professional and Consultancy Charges118834000Rent21721000Repairs and maintenance4039000Insurance expenses35433000Fees, Rates and taxes6729000Sales and Marketing Expenses23421000Cloud Hosting and Communication Charges55136000Payments to auditors4870000Bank Charges40982000Miscellaneous expenses50907000238240000012827160001121090000000007644000764400051920002950001431780000001966850005981380000074769000869592000108740004437200092483800000235661800016705300078006000245059000514351000759410000371911000000136890003856000001990600000040550600067242000089400024429600024519000021865900011362690005006800053650000011917020000015972080002356618000161456000013158800002439700007080000-631550000-156785000000790330000-365000-154000016890000-2346040000008265000-6459000001312000000-21079000-475506000000115500000-487056000000000000000000000000000000000-5278000-52780000011563690000000010390590001083645000001079430000010038400005115060005094700056245300035685000598138000-2243000-24260000022430002426000AuditedtrueM/s K Gopal Rao & Cotrue2027-02-28